Breaking Finance News

Tandem Diabetes Care Inc (NASDAQ:TNDM) stock price target raised to $10.00, reported earlier today by B. Riley

Just yesterday Tandem Diabetes Care Inc (NASDAQ:TNDM) traded -3.09% lower at $8.15. The company’s 50-day moving average is $7.10 and its 200-day moving average is $7.83. With the last close up 4.06% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 133,700 shares of TNDM traded, down from an avg. volume of 193,038

B. Riley raised the target price of Tandem Diabetes Care Inc (NASDAQ:TNDM) to $10.00 stating a potential upside of 0.23%.

Recent Performance Chart

Tandem Diabetes Care Inc (NASDAQ:TNDM)

Tandem Diabetes Care Inc has with a 52 week low of $6.04 and a 52 week high of $12.48 and has a market capitalization of $0.

In addition to B. Riley reporting its stock price target, a total of 8 analysts have released a report on the company. The average stock price target is $15.84 with 5 firms rating the stock a strong buy, two equity analysts rating the company a buy, three brokerages rating the company a hold, 0 firms rating the stock a underperform, and finally 0 equity analysts rating the company a sell.

General Company Details For Tandem Diabetes Care Inc (NASDAQ:TNDM)

Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *